Mark  Rubinstein  to  Interleukin-17
                            
                            
                                This is a "connection" page, showing publications  Mark  Rubinstein  has written about  Interleukin-17.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.179
         
        
        
     
 
    
        
        - 
            Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic. Cancer Immunol Immunother. 2016 Mar; 65(3):247-59.
            
            
                Score: 0.122
            
         
        
        - 
            Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling. Clin Cancer Res. 2015 Jun 01; 21(11):2546-57.
            
            
                Score: 0.029
            
         
        
        - 
            The inducible costimulator augments Tc17 cell responses to self and tumor tissue. J Immunol. 2015 Feb 15; 194(4):1737-47.
            
            
                Score: 0.028